Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Benezra
Sloan Kettering Inst Can Research, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
AngioGenex, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Benezra has financial interests with the entity AngioGenex, Inc. Aim 3 in Project 2 of this grant explores the inhibition of Id via the use of small molecules, one of which is manufactured by Angiogenex. Dr. Benezra's financial interests with an entity that manufactures a molecule used in the research presents at least the perception of a conflict of interest that should be managed.
Program Project in Models of Breast Cancer
Almost all cancer deaths are due to the growth of functionally disruptive lesions in metastatic sites. This proposal uses animal and laboratory models to dissect an interlinking network of molecular signals and pathways to lead to better prognostic and predictive clinical tests and more effective, less toxic treatments that target such aberrations.
Filed on July 19, 2019.
Tell us what you know about Robert Benezra's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Robert Benezra”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert Benezra | Sloan Kettering Inst Can Research | Conflict of Interest | AngioGenex, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.